Corcept Therapeutics (CORT) Ukubelenga kwa Stock
Corcept Therapeutics
Cipimo ca AI : CORT
AI ileposa chilango ca nshita ya kucila ku bushiku bumo bwa kucita malishiti, ku mpela ya mulungu na ku mpela ya mweshi. Ukukula kulapimwa ukutula ku nshita ya kucila. Aya ni makani ya statistics, te malangililo ya kubika ndalama.
Ipimo mu nshiku 6 ishacita
Premium ilasanga ifyo AI ilatasha ukucita pa 1 day, 1 week na 1 month pa stock iyi na pa stock shonse shimbi.
Fungula Premium🔒 Ukukwata kwa ifipimo
Umulandu wa forecast — bonse ba kale pamo na nshita ya kucila — ni cipande ca Premium.
Fungula PremiumPa Kampani Ici
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the development of drugs for the treatment of serious metabolic and psychiatric disorders. The company’s main product modifies the action of cortisol, also known as the “stress hormone,” by blocking cortisol’s binding to one of two known receptors—the type 2 glucocorticoid receptor.
